Geode Capital Management
MREO

Geode Capital Management’s Mereo BioPharma MREO Stock Holding History

Geode Capital Management’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-92,534
Closed -$30.5K – 4529
2026
Q1 		$30.5K Hold
92,534
– – ﹤0.01% 4407
2025
Q4 		$38.6K Hold
92,534
– – ﹤0.01% 4281
2025
Q3 		$191K Hold
92,534
– – ﹤0.01% 3938
2025
Q2 		$251K Buy
92,534
+378
+0.4% +$912 ﹤0.01% 3797
2025
Q1 		$207K Hold
92,156
– – ﹤0.01% 3841
2024
Q4 		$323K Hold
92,156
– – ﹤0.01% 3740
2024
Q3 		$379K Hold
92,156
– – ﹤0.01% 3695
2024
Q2 		$332K Sell
92,156
-4,474
-5% -$14.5K ﹤0.01% 3728
2024
Q1 		$319K Hold
96,630
– – ﹤0.01% 3777
2023
Q4 		$223K Hold
96,630
– – ﹤0.01% 3903
2023
Q3 		$125K Hold
96,630
– – ﹤0.01% 4169
2023
Q2 		$128K Hold
96,630
– – ﹤0.01% 4241
2023
Q1 		$68.3K Hold
96,630
– – ﹤0.01% 4450
2022
Q4 		$72K Hold
96,630
– – ﹤0.01% 4499
2022
Q3 		$83K Hold
96,630
– – ﹤0.01% 4634
2022
Q2 		$108K Hold
96,630
– – ﹤0.01% 4560
2022
Q1 		$108K Hold
96,630
– – ﹤0.01% 4635
2021
Q4 		$154K Hold
96,630
– – ﹤0.01% 4589
2021
Q3 		$233K Hold
96,630
– – ﹤0.01% 4374
2021
Q2 		$306K Buy
96,630
+63,643
+193% +$214K ﹤0.01% 4157
2021
Q1 		$111K Buy
+32,987
New +$117K ﹤0.01% 4277

Other funds holding MREO

TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JJBC
James J. Burns & Company Melville, New York $924M AUM 22.18% 1-Year Est. Return
JF
JMN Financial New Albany, Ohio $129M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Geode Capital Management's MREO Position: Q2 2026 in Review

Geode Capital Management sold out of Mereo BioPharma (MREO) in Q2 2026, closing a stake of 92,534 shares — an estimated $30.5K sold.

Geode Capital Management first reported a position in MREO in Q1 2021 and held it in 21 quarters. The position peaked at $379K in Q3 2024. 38 funds tracked by Wall St. Rank hold MREO as of Q2 2026.

  • Geode Capital Management reported no remaining Mereo BioPharma position as of Q2 2026 after selling out during the quarter.
  • Geode Capital Management sold 92,534 Mereo BioPharma shares in Q2 2026, an estimated $30.5K.
  • Geode Capital Management first reported a position in Mereo BioPharma in Q1 2021 and held it in 21 quarters.
  • Geode Capital Management's Mereo BioPharma position peaked at $379K in Q3 2024.
  • 38 funds tracked by Wall St. Rank held Mereo BioPharma as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.